OCM
CVS icon

Orleans Capital Management’s CVS Health CVS Stock Holding History

Orleans Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,635
Closed -$344K – 82
2023
Q1 		$344K Sell
4,635
-675
-13% -$56.6K 0.25% 62
2022
Q4 		$495K Sell
5,310
-775
-13% -$74.8K 0.38% 52
2022
Q3 		$580K Sell
6,085
-100
-2% -$9.9K 0.49% 49
2022
Q2 		$573K Buy
6,185
+3,450
+126% +$337K 0.43% 52
2022
Q1 		$277K Buy
+2,735
New +$287K 0.17% 71
2019
Q3 		– Sell
-5,075
Closed -$277K – 83
2019
Q2 		$277K Sell
5,075
-16,395
-76% -$883K 0.21% 75
2019
Q1 		$1.16M Buy
21,470
+4,600
+27% +$284K 0.89% 48
2018
Q4 		$1.1M Sell
16,870
-6,750
-29% -$504K 1.03% 36
2018
Q3 		$1.86M Buy
23,620
+5,785
+32% +$414K 1.28% 39
2018
Q2 		$1.15M Buy
17,835
+9,160
+106% +$604K 0.83% 46
2018
Q1 		$540K Sell
8,675
-3,400
-28% -$244K 0.4% 60
2017
Q4 		$875K Buy
+12,075
New +$878K 0.62% 54

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Orleans Capital Management's CVS Position: Q2 2023 in Review

Orleans Capital Management sold out of CVS Health (CVS) in Q2 2023, closing a stake of 4,635 shares — an estimated $344K sold.

Orleans Capital Management first reported a position in CVS in Q4 2017 and held it in 12 quarters. The position peaked at $1.86M in Q3 2018. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Orleans Capital Management reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Orleans Capital Management sold 4,635 CVS Health shares in Q2 2023, an estimated $344K.
  • Orleans Capital Management first reported a position in CVS Health in Q4 2017 and held it in 12 quarters.
  • Orleans Capital Management's CVS Health position peaked at $1.86M in Q3 2018.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Orleans Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.